Lupin’s Pegfilgrastim Biosimilar Accepted By US FDA

Neulasta Rival Faces A Crowded Market With Four Approved Competitors

 
• By David Wallace
Motorbike Race Track Motorcycle
Lupin is planning to join a crowded field for biosimilar pegfilgrastim • Source: Alamy

More from Biosimilars

More from Products